首页 > 最新文献

Alternative therapies in health and medicine最新文献

英文 中文
Comparative Efficacy of Traditional Unani Medicine Formulations Versus Apremilast for Chronic Plaque Psoriasis: A Randomized Controlled Trial. 传统Unani药物制剂与阿普米司特治疗慢性斑块型银屑病的疗效比较:一项随机对照试验。
IF 1.9 4区 医学 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-09-24
Sabreena Bashir, Muzafar Din Ahmad Bhat, Mohd Arshad Jamal, Ruksar Ayesha

Background: Psoriasis remains an incurable and recurrent condition despite modern treatment. Traditional Unani Medicine recommends numerous formulations for psoriasis, but with little supporting scientific evidence.

Primary study objectives: The study aimed to evaluate the efficacy and safety of Majoon Mundi and Roghan Gul compared to apremilast and coconut oil in managing chronic plaque psoriasis (CPP).

Methods/design: The study was a randomized, open-label, standard-controlled clinical trial, with 33 participants. 20 patients completed the 6-week treatment course in the test group, while 10 patients completed the 6-week treatment course in the control group.

Setting: The study was conducted at the National Institute of Unani Medicine (NIUM), Bangalore, India, from June 2021 to December 2021.

Participants: Participants aged 18-60 years, of either gender, diagnosed with CPP, and based on psoriasis area and severity index (PASI) score.

Interventions: The participants in the test group received 10 g of Majoon Mundi orally twice daily after meals and Roghan Gul for topical use twice daily, while the participants in the active control group received apremilast orally in a titrated dose and coconut oil as a topical application twice daily.

Outcome measures: The primary outcome of the study was a reduction in PASI score, and the secondary outcome was a reduction in dermatology life quality index (DLQI) score. Photographic assessments were conducted at the 14th, 28th, and 42nd day of the follow-up period.

Results: Intragroup analyses revealed that the test and control groups experienced a statistically significant reduction in PASI and DLQI scores (P < .001). Intergroup analysis showed no statistically significant difference in the reduction of PASI and DLQI scores between groups (P = .772 and .775, respectively).

Conclusion: This study found that together, Majoon Mundi and Roghan Gul are as effective as apremilast and coconut oil in decreasing PASI and DLQI scores for managing CPP.

Keywords: apremilast, comparative study, herbal medicine, psoriasis, unani medicine.

背景:尽管有现代治疗,牛皮癣仍然是一种无法治愈和复发的疾病。传统的Unani医学推荐了许多治疗牛皮癣的配方,但几乎没有支持的科学证据。主要研究目标:该研究旨在评估majoron Mundi和Roghan Gul在治疗慢性斑块性银屑病(CPP)方面的疗效和安全性,并与阿普米司特和椰子油进行比较。方法/设计:该研究是一项随机、开放标签、标准对照的临床试验,共有33名参与者。试验组20例患者完成6周疗程,对照组10例患者完成6周疗程。背景:该研究于2021年6月至2021年12月在印度班加罗尔的国立Unani医学研究所(NIUM)进行。参与者:年龄在18-60岁之间,男女不限,诊断为CPP,基于牛皮癣面积和严重程度指数(PASI)评分。干预措施:试验组的参与者在饭后口服10克曼迪,每日两次,局部使用Roghan Gul,每日两次,而积极对照组的参与者口服阿普雷米司特,剂量为滴剂,椰子油作为局部应用,每日两次。结局指标:研究的主要结局是PASI评分的降低,次要结局是皮肤病生活质量指数(DLQI)评分的降低。随访期第14、28、42天进行影像学评估。结果:组内分析显示,实验组和对照组的PASI和DLQI评分均有统计学意义的降低(P < 0.001)。组间分析显示,两组患者PASI和DLQI评分的降低差异无统计学意义(P = .772和。775年,分别)。结论:本研究发现,majon Mundi和Roghan Gul在降低PASI和DLQI评分治疗CPP方面与阿普米司特和椰子油一样有效。关键词:阿普米司特,比较研究,草药,银屑病,乌纳尼药。
{"title":"Comparative Efficacy of Traditional Unani Medicine Formulations Versus Apremilast for Chronic Plaque Psoriasis: A Randomized Controlled Trial.","authors":"Sabreena Bashir, Muzafar Din Ahmad Bhat, Mohd Arshad Jamal, Ruksar Ayesha","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Psoriasis remains an incurable and recurrent condition despite modern treatment. Traditional Unani Medicine recommends numerous formulations for psoriasis, but with little supporting scientific evidence.</p><p><strong>Primary study objectives: </strong>The study aimed to evaluate the efficacy and safety of Majoon Mundi and Roghan Gul compared to apremilast and coconut oil in managing chronic plaque psoriasis (CPP).</p><p><strong>Methods/design: </strong>The study was a randomized, open-label, standard-controlled clinical trial, with 33 participants. 20 patients completed the 6-week treatment course in the test group, while 10 patients completed the 6-week treatment course in the control group.</p><p><strong>Setting: </strong>The study was conducted at the National Institute of Unani Medicine (NIUM), Bangalore, India, from June 2021 to December 2021.</p><p><strong>Participants: </strong>Participants aged 18-60 years, of either gender, diagnosed with CPP, and based on psoriasis area and severity index (PASI) score.</p><p><strong>Interventions: </strong>The participants in the test group received 10 g of Majoon Mundi orally twice daily after meals and Roghan Gul for topical use twice daily, while the participants in the active control group received apremilast orally in a titrated dose and coconut oil as a topical application twice daily.</p><p><strong>Outcome measures: </strong>The primary outcome of the study was a reduction in PASI score, and the secondary outcome was a reduction in dermatology life quality index (DLQI) score. Photographic assessments were conducted at the 14th, 28th, and 42nd day of the follow-up period.</p><p><strong>Results: </strong>Intragroup analyses revealed that the test and control groups experienced a statistically significant reduction in PASI and DLQI scores (P < .001). Intergroup analysis showed no statistically significant difference in the reduction of PASI and DLQI scores between groups (P = .772 and .775, respectively).</p><p><strong>Conclusion: </strong>This study found that together, Majoon Mundi and Roghan Gul are as effective as apremilast and coconut oil in decreasing PASI and DLQI scores for managing CPP.</p><p><strong>Keywords: </strong>apremilast, comparative study, herbal medicine, psoriasis, unani medicine.</p>","PeriodicalId":7571,"journal":{"name":"Alternative therapies in health and medicine","volume":" ","pages":""},"PeriodicalIF":1.9,"publicationDate":"2025-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145123906","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploring the Role of Yoga and Naturopathy as Complementary Therapies in Chronic Kidney Disease Management: A Case Study. 探索瑜伽和自然疗法作为补充疗法在慢性肾脏疾病管理中的作用:一个案例研究。
IF 1.9 4区 医学 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-09-24
K Harshini, V R Abitone, Shivaprasad Shetty

Background: Chronic kidney disease (CKD) is a progressive condition often associated with hypertension and diabetes, leading to impaired renal function and poor quality of life.

Objective: This study employed alternative and holistic approaches to enhance kidney function in a 56-year-old male diagnosed with CKD in 2021, hypertension in January 2021, and diabetes mellitus type 2 in 2022, who presented with worsening renal function and back pain symptoms.

Study design: Single-patient case study at a single centre.

Intervention: A 12-day intervention based on an integrated naturopathy and yoga approach was provided, which included therapeutic yoga, diet, hydrotherapy, manipulative, and relaxation techniques.

Setting: Sri Dharmasthala Manjunatheshwara Yoga and Nature Cure Hospital, Dharmasthala, India.

Outcome measures: General parameters (weight and body mass index), blood pressure (systolic and diastolic), kidney profile (creatinine and urea), urine profile (protein and sugar), blood glucose (fasting blood sugar and postprandial blood sugar), and pain (using Visual Analog Scale).

Results: Post-treatment evaluation showed a notable improvement in his fasting blood sugar (15%), postprandial blood sugar (32%), blood pressure (~10%), serum creatinine (32%), proteinuria, glycosuria, and pain score relief (60-80%).

Conclusion: This suggests that an integrated yoga and naturopathy approach may be considered an alternative or adjunct treatment for managing CKD. However, additional research is needed to validate these findings.

Keywords: chronic kidney disease, yoga, naturopathy, diet, case study.

背景:慢性肾脏疾病(CKD)是一种进行性疾病,通常与高血压和糖尿病相关,导致肾功能受损和生活质量下降。目的:本研究对一名56岁男性患者,于2021年诊断为CKD, 2021年1月诊断为高血压,2022年诊断为2型糖尿病,肾功能恶化,背部疼痛症状,采用替代和整体方法增强肾功能。研究设计:单个中心的单个患者病例研究。干预:提供为期12天的综合自然疗法和瑜伽方法的干预,包括治疗性瑜伽,饮食,水疗,手法和放松技术。地点:Sri Dharmasthala Manjunatheshwara瑜伽和自然治疗医院,Dharmasthala,印度。结果测量:一般参数(体重和体重指数)、血压(收缩压和舒张压)、肾脏特征(肌酐和尿素)、尿液特征(蛋白质和糖)、血糖(空腹血糖和餐后血糖)和疼痛(使用视觉模拟量表)。结果:治疗后评估显示,患者空腹血糖(15%)、餐后血糖(32%)、血压(~10%)、血清肌酐(32%)、蛋白尿、糖尿、疼痛评分缓解(60-80%)显著改善。结论:这表明,综合瑜伽和自然疗法可以被认为是治疗慢性肾病的替代或辅助治疗方法。然而,需要进一步的研究来验证这些发现。关键词:慢性肾病,瑜伽,自然疗法,饮食,案例研究
{"title":"Exploring the Role of Yoga and Naturopathy as Complementary Therapies in Chronic Kidney Disease Management: A Case Study.","authors":"K Harshini, V R Abitone, Shivaprasad Shetty","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Chronic kidney disease (CKD) is a progressive condition often associated with hypertension and diabetes, leading to impaired renal function and poor quality of life.</p><p><strong>Objective: </strong>This study employed alternative and holistic approaches to enhance kidney function in a 56-year-old male diagnosed with CKD in 2021, hypertension in January 2021, and diabetes mellitus type 2 in 2022, who presented with worsening renal function and back pain symptoms.</p><p><strong>Study design: </strong>Single-patient case study at a single centre.</p><p><strong>Intervention: </strong>A 12-day intervention based on an integrated naturopathy and yoga approach was provided, which included therapeutic yoga, diet, hydrotherapy, manipulative, and relaxation techniques.</p><p><strong>Setting: </strong>Sri Dharmasthala Manjunatheshwara Yoga and Nature Cure Hospital, Dharmasthala, India.</p><p><strong>Outcome measures: </strong>General parameters (weight and body mass index), blood pressure (systolic and diastolic), kidney profile (creatinine and urea), urine profile (protein and sugar), blood glucose (fasting blood sugar and postprandial blood sugar), and pain (using Visual Analog Scale).</p><p><strong>Results: </strong>Post-treatment evaluation showed a notable improvement in his fasting blood sugar (15%), postprandial blood sugar (32%), blood pressure (~10%), serum creatinine (32%), proteinuria, glycosuria, and pain score relief (60-80%).</p><p><strong>Conclusion: </strong>This suggests that an integrated yoga and naturopathy approach may be considered an alternative or adjunct treatment for managing CKD. However, additional research is needed to validate these findings.</p><p><strong>Keywords: </strong>chronic kidney disease, yoga, naturopathy, diet, case study.</p>","PeriodicalId":7571,"journal":{"name":"Alternative therapies in health and medicine","volume":" ","pages":""},"PeriodicalIF":1.9,"publicationDate":"2025-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145123904","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fasd (Venesection) as a Treatment Option for Sciatica (Irq al-Nasa): A Case Report. Fasd(静脉切断术)作为坐骨神经痛的治疗选择(伊拉克-美国宇航局):一例报告。
IF 1.9 4区 医学 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-09-24
X Saliha, Faizan Khan, Syed Faisal Ali, Mohammad Naseem Khan, Ehsan Ahmad

Background: Sciatica is a type of musculoskeletal pain experienced in the leg along the distribution of the sciatic nerve. It is occasionally accompanied by lower backache. According to the Unani system of medicine, Irq al-Nasa (Sciatica) is a form of Wajaul Mafasil (Arthritis), characterised by hip pain that travels from the back of the thigh to the ankle joint. Conventional treatments for Sciatica typically involve medication, surgery, or occasionally both. The use of corticosteroids and painkillers is associated with a higher risk of adverse events, and their effectiveness is also questionable. This warrants the need for an effective, complementary treatment option for Sciatica.

Aim: This case report aims to evaluate the efficacy of Fasd (Venesection) in managing Irq al-Nasa.

Case description: The patient was a 63-year-old non-hypertensive, non-diabetic, euthyroid male, complaining of persistent left-sided pain in the upper thigh, lower buttock region, with pain radiating to the left leg, calf, and toes, along with numbness and tingling sensations. Sciatica was diagnosed based on three objective criteria: Visual Analogue Scale (VAS) pain score, Oswestry Disability Index (ODI), and Straight Leg Raising Test (SLRT), as well as from magnetic resonance imaging (MRI) of the lumbo-sacral spine.

Intervention: Fasd (Venesection) was performed on the left saphenous minor vein of the patient once a week for two weeks. The patients were assessed using VAS, ODI, and SLRT.

Outcome: Before the intervention, the VAS score was 8, the ODI was 42%, and the SLR was 30%. Following the first Fasd procedure, the VAS score decreased to 4, the ODI reduced to 22%, and the SLR improved to 60%. After the second procedure, the VAS score reached 0, the ODI further dropped to 8%, and the SLR increased to 90%.

Conclusion: This case report provides preliminary evidence supporting the use of Fasd in treating Sciatica.

Keywords: Fasd, Venesection, Sciatica, Irq al-Nasa, pain management, case report.

背景:坐骨神经痛是一种沿坐骨神经分布的腿部肌肉骨骼疼痛。偶尔伴有腰痛。根据Unani医学系统,坐骨神经痛是关节炎的一种形式,其特征是臀部疼痛从大腿后部传播到踝关节。坐骨神经痛的传统治疗通常包括药物、手术或两者兼而有之。皮质类固醇和止痛药的使用与较高的不良事件风险相关,其有效性也值得怀疑。这证明了坐骨神经痛需要一种有效的补充治疗方案。目的:本病例报告旨在评价Fasd(静脉切断术)治疗伊拉克al-Nasa的疗效。病例描述:患者63岁,非高血压、非糖尿病、甲状腺功能正常,男性,主诉左侧大腿上部、臀部下部持续疼痛,疼痛放射至左腿、小腿和脚趾,伴麻木和刺痛感。坐骨神经痛的诊断依据三个客观标准:视觉模拟评分(VAS)疼痛评分、Oswestry残疾指数(ODI)和直腿抬高试验(SLRT),以及腰骶棘磁共振成像(MRI)。干预措施:对患者左侧小隐静脉行Fasd(静脉切断术),每周一次,连续两周。采用VAS、ODI和SLRT对患者进行评估。结果:干预前VAS评分为8分,ODI为42%,SLR为30%。第一次Fasd手术后,VAS评分降至4分,ODI降至22%,SLR提高至60%。第二次手术后,VAS评分达到0分,ODI进一步下降到8%,SLR提高到90%。结论:本病例报告为支持Fasd治疗坐骨神经痛提供了初步证据。关键词:Fasd,静脉切断术,坐骨神经痛,伊拉克al-Nasa,疼痛管理,病例报告。
{"title":"Fasd (Venesection) as a Treatment Option for Sciatica (Irq al-Nasa): A Case Report.","authors":"X Saliha, Faizan Khan, Syed Faisal Ali, Mohammad Naseem Khan, Ehsan Ahmad","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Sciatica is a type of musculoskeletal pain experienced in the leg along the distribution of the sciatic nerve. It is occasionally accompanied by lower backache. According to the Unani system of medicine, Irq al-Nasa (Sciatica) is a form of Wajaul Mafasil (Arthritis), characterised by hip pain that travels from the back of the thigh to the ankle joint. Conventional treatments for Sciatica typically involve medication, surgery, or occasionally both. The use of corticosteroids and painkillers is associated with a higher risk of adverse events, and their effectiveness is also questionable. This warrants the need for an effective, complementary treatment option for Sciatica.</p><p><strong>Aim: </strong>This case report aims to evaluate the efficacy of Fasd (Venesection) in managing Irq al-Nasa.</p><p><strong>Case description: </strong>The patient was a 63-year-old non-hypertensive, non-diabetic, euthyroid male, complaining of persistent left-sided pain in the upper thigh, lower buttock region, with pain radiating to the left leg, calf, and toes, along with numbness and tingling sensations. Sciatica was diagnosed based on three objective criteria: Visual Analogue Scale (VAS) pain score, Oswestry Disability Index (ODI), and Straight Leg Raising Test (SLRT), as well as from magnetic resonance imaging (MRI) of the lumbo-sacral spine.</p><p><strong>Intervention: </strong>Fasd (Venesection) was performed on the left saphenous minor vein of the patient once a week for two weeks. The patients were assessed using VAS, ODI, and SLRT.</p><p><strong>Outcome: </strong>Before the intervention, the VAS score was 8, the ODI was 42%, and the SLR was 30%. Following the first Fasd procedure, the VAS score decreased to 4, the ODI reduced to 22%, and the SLR improved to 60%. After the second procedure, the VAS score reached 0, the ODI further dropped to 8%, and the SLR increased to 90%.</p><p><strong>Conclusion: </strong>This case report provides preliminary evidence supporting the use of Fasd in treating Sciatica.</p><p><strong>Keywords: </strong>Fasd, Venesection, Sciatica, Irq al-Nasa, pain management, case report.</p>","PeriodicalId":7571,"journal":{"name":"Alternative therapies in health and medicine","volume":" ","pages":""},"PeriodicalIF":1.9,"publicationDate":"2025-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145123899","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Integrated Transcriptomic Analysis Reveals Shared Molecular Signatures Between Asthma and Chronic Obstructive Pulmonary Disease. 综合转录组学分析揭示哮喘和慢性阻塞性肺疾病之间的共同分子特征。
IF 1.9 4区 医学 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-09-24
Arman Mokaram Doust Delkhah, Milad Sheervalilou, Shahram Parvin, Masoud Arabfard

Background: Asthma and chronic obstructive pulmonary disease (COPD) are prevalent respiratory conditions with overlapping pathogenic features such as chronic inflammation.

Primary study objective: This study aimed to identify key contributors and pathways that are common to both of these disorders, potentially allowing for the detection of therapeutic targets, particularly for patients with asthma-COPD overlap syndrome.

Methods: Using an integrated transcriptomics approach, eight datasets were analyzed, including two each for COPD and asthma, in both blood and airway epithelial cells. Thereafter, by identifying shared differentially expressed genes between COPD and asthma, protein-protein interaction and miRNA-mRNA regulatory networks were constructed for blood and epithelial cells, and hub genes were determined. Lastly, functional enrichment analysis was conducted to determine the biological functions of the discovered shared protein-protein interaction (PPI) networks.

Results: The construction of shared PPI networks for these two respiratory disorders highlighted key hub genes, including ribosomal proteins and IL-1β in blood and CTNNB1 in airway epithelial cells. Two members of the miR-30 family, including miR-30a-3p and miR-30e-3p, were discerned as multi-target regulators of hub genes in both networks of blood and airway epithelial cells. Infection-related pathways were substantially enriched, as revealed by functional analysis of shared networks for both blood and airway epithelial cells.

Conclusion: IL-1β signaling may serve as a potential link between asthma and COPD, since it was identified as a hub gene in the shared network of blood. Likewise, downregulated CTNNB1 was discerned as a key gene in the shared network of airway epithelial samples.

Keywords: asthma, chronic obstructive pulmonary disease, transcriptome, gene expression profiling, systems biology.

背景:哮喘和慢性阻塞性肺疾病(COPD)是常见的呼吸系统疾病,具有重叠的致病特征,如慢性炎症。主要研究目的:本研究旨在确定这两种疾病共同的关键因素和途径,潜在地允许检测治疗靶点,特别是哮喘- copd重叠综合征患者。方法:采用整合转录组学方法,分析了血液和气道上皮细胞中的8个数据集,其中COPD和哮喘各2个。随后,通过鉴定COPD与哮喘之间共有的差异表达基因,构建血液细胞和上皮细胞的蛋白-蛋白相互作用和miRNA-mRNA调控网络,确定中枢基因。最后,进行功能富集分析以确定发现的共享蛋白-蛋白相互作用(PPI)网络的生物学功能。结果:这两种呼吸系统疾病的共享PPI网络的构建突出了关键枢纽基因,包括血液中的核糖体蛋白和IL-1β以及气道上皮细胞中的CTNNB1。miR-30家族的两个成员,包括miR-30a-3p和miR-30e-3p,被认为是血液和气道上皮细胞网络中枢纽基因的多靶点调节因子。正如血液和气道上皮细胞共享网络的功能分析所揭示的那样,感染相关通路大量富集。结论:IL-1β信号可能是哮喘和COPD之间的潜在联系,因为它被确定为血液共享网络中的枢纽基因。同样,下调的CTNNB1被认为是气道上皮样本共享网络中的关键基因。关键词:哮喘,慢性阻塞性肺疾病,转录组,基因表达谱,系统生物学。
{"title":"Integrated Transcriptomic Analysis Reveals Shared Molecular Signatures Between Asthma and Chronic Obstructive Pulmonary Disease.","authors":"Arman Mokaram Doust Delkhah, Milad Sheervalilou, Shahram Parvin, Masoud Arabfard","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Asthma and chronic obstructive pulmonary disease (COPD) are prevalent respiratory conditions with overlapping pathogenic features such as chronic inflammation.</p><p><strong>Primary study objective: </strong>This study aimed to identify key contributors and pathways that are common to both of these disorders, potentially allowing for the detection of therapeutic targets, particularly for patients with asthma-COPD overlap syndrome.</p><p><strong>Methods: </strong>Using an integrated transcriptomics approach, eight datasets were analyzed, including two each for COPD and asthma, in both blood and airway epithelial cells. Thereafter, by identifying shared differentially expressed genes between COPD and asthma, protein-protein interaction and miRNA-mRNA regulatory networks were constructed for blood and epithelial cells, and hub genes were determined. Lastly, functional enrichment analysis was conducted to determine the biological functions of the discovered shared protein-protein interaction (PPI) networks.</p><p><strong>Results: </strong>The construction of shared PPI networks for these two respiratory disorders highlighted key hub genes, including ribosomal proteins and IL-1β in blood and CTNNB1 in airway epithelial cells. Two members of the miR-30 family, including miR-30a-3p and miR-30e-3p, were discerned as multi-target regulators of hub genes in both networks of blood and airway epithelial cells. Infection-related pathways were substantially enriched, as revealed by functional analysis of shared networks for both blood and airway epithelial cells.</p><p><strong>Conclusion: </strong>IL-1β signaling may serve as a potential link between asthma and COPD, since it was identified as a hub gene in the shared network of blood. Likewise, downregulated CTNNB1 was discerned as a key gene in the shared network of airway epithelial samples.</p><p><strong>Keywords: </strong>asthma, chronic obstructive pulmonary disease, transcriptome, gene expression profiling, systems biology.</p>","PeriodicalId":7571,"journal":{"name":"Alternative therapies in health and medicine","volume":" ","pages":""},"PeriodicalIF":1.9,"publicationDate":"2025-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145123910","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Efficiency of Curcumin and Fish Oil During the Formation of Pressure Ulcers in Mice: Do Curcumin and Fish Oil Prevent and Heal Pressure Ulcers? 姜黄素和鱼油在小鼠压疮形成过程中的作用:姜黄素和鱼油能预防和治愈压疮吗?
IF 1.9 4区 医学 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-09-24
Sevil Tultak, Ebru Karakoc, Birgul Yelken, Emine Dundar
<p><strong>Context: </strong>PUs increase mortality in intensive care units and the cost of hospital stays by prolonging the actual treatment process.</p><p><strong>Objective: </strong>The study, in a mouse model, aimed to investigate the efficacy of curcumin and fish oil in preventing and healing PUs by administiring them simultaneously intraperitoneally.</p><p><strong>Design: </strong>The research team performed an animal study.</p><p><strong>Setting: </strong>The study took place at Eskişehir Osmangazi University's Medical and Surgical, Experimental Animal Practice Center.</p><p><strong>Animals: </strong>The animals were 28 healthy, female Balb c mice, eight weeks of age weighing about 30 grams.</p><p><strong>Intervention: </strong>The research team induced PUs in all mice using neodymium magnets capable of forming approximately 1000 Gauss of magnetic force.The team randomly divided the mice into four groups,with seven animals in each group: (1) the control group,which received an injecition if dimethyl sulfoxide (DMSO) only; (2) the curcumin group,which received an injection of 200 mg/kg of curcumin in DMSO; (3) the fish oil group,which received an injection of fish oil; and (4) the curcumin+fish oil group,which received an injection of 200 mg/kg of curcumin in DMSO and fish oil.The mice received all injections intraperitoneally.</p><p><strong>Outcome measures: </strong>To determine a wound's severity, the healing process, and nonhealing tissue, the research team examined the tissues separately: (1) dor degree of ulceration, (2) inflammation, (3) reepithelization, (4) neovascularization, and (5) granulation.</p><p><strong>Results: </strong>The study found third-degree pressure ulcer in all groups. No significant differences existed between the groups in terms of inflammation, which occurred in the control group with a maximum rate of 41.2%. The formation of reepithelization showed a significant difference between groups. Complete reepithelization ratios was higher in the fish oil group with 50% than the curcumin group and curcumin + fish oil group with 25%. Partiel reepithelization was seen with 46.1% highest ratio in curcumin + fish oil group. For neovascularization, the highest rate occurred in the curcumin +fish oil group at 75% at >10 vessels per high power field (HPF) variable, and second highest ratio with 25% was curcumin group. Also 6-10 vessels per HPF (100%) was seen 42.9% in curcumin group and 42.9% in curcumin and fish oil group. Thus, amount of vessels were more in curcumin and fish oil group and curcumin group than control group and fish oil group. For formation of 3th degree granulation, the highest rate occurred in the fish oil group at 46.2% and second highest ratio was seen in curcumin + fish oil group with 38%. 2nd degree granulation was seen 55.6% in curcumin group. Thus, giving treatment induces the granulation that seen the lowest granulation in control group with 100%.</p><p><strong>Conclusions: </strong>The current res
背景:脓液通过延长实际治疗过程而增加重症监护病房的死亡率和住院费用。目的:建立小鼠模型,探讨姜黄素和鱼油同时腹腔给药对脓肿的预防和愈合作用。设计:研究小组进行了动物实验。环境:该研究在eskiehir Osmangazi大学医学和外科实验动物实践中心进行。动物:这些动物是28只健康的雌性Balb c小鼠,8周龄,体重约30克。干预:研究小组使用能够形成约1000高斯磁力的钕磁铁在所有小鼠中诱导脓肿。研究小组将小鼠随机分为四组,每组7只:(1)对照组,只注射二甲亚砜(DMSO);(2)姜黄素组,在DMSO中注射200 mg/kg姜黄素;(3)鱼油组,注射鱼油;(4)姜黄素+鱼油组,在DMSO和鱼油中注射200 mg/kg姜黄素。所有小鼠均接受腹腔注射。结果测量:为了确定伤口的严重程度、愈合过程和未愈合组织,研究小组分别检查了组织:(1)溃疡程度,(2)炎症,(3)再上皮化,(4)新生血管,(5)肉芽。结果:各组均出现三度压疮。两组间炎症发生率无显著差异,对照组炎症发生率最高,为41.2%。再上皮的形成在两组间有显著差异。鱼油组的完全再上皮率(50%)高于姜黄素组和姜黄素+鱼油组(25%)。姜黄素+鱼油组颗粒再上皮率最高,为46.1%。对于新生血管,姜黄素+鱼油组的新生血管率最高,为75%,每高倍场(HPF)变量为bbb10容器,姜黄素组的新生血管率第二高,为25%。在姜黄素组和姜黄素和鱼油组中,每HPF有6-10个血管(100%)。由此可见,姜黄素和鱼油组及姜黄素组血管数量均高于对照组和鱼油组。鱼油组的3度肉芽形成率最高,为46.2%,姜黄素+鱼油组次之,为38%。姜黄素组2度肉芽化率为55.6%。由此可见,给药组肉芽率为100%,对照组肉芽率最低。结论:目前的研究建议使用姜黄素、鱼油和姜黄素+鱼油,腹腔加压应用,治疗急性脓肿。姜黄素+鱼油可以防止伤口变成慢性伤口,减少脓液引起的并发症,并提供更快的恢复,从而降低成本。关键词:压疮,姜黄素,鱼油。
{"title":"The Efficiency of Curcumin and Fish Oil During the Formation of Pressure Ulcers in Mice: Do Curcumin and Fish Oil Prevent and Heal Pressure Ulcers?","authors":"Sevil Tultak, Ebru Karakoc, Birgul Yelken, Emine Dundar","doi":"","DOIUrl":"","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Context: &lt;/strong&gt;PUs increase mortality in intensive care units and the cost of hospital stays by prolonging the actual treatment process.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Objective: &lt;/strong&gt;The study, in a mouse model, aimed to investigate the efficacy of curcumin and fish oil in preventing and healing PUs by administiring them simultaneously intraperitoneally.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Design: &lt;/strong&gt;The research team performed an animal study.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Setting: &lt;/strong&gt;The study took place at Eskişehir Osmangazi University's Medical and Surgical, Experimental Animal Practice Center.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Animals: &lt;/strong&gt;The animals were 28 healthy, female Balb c mice, eight weeks of age weighing about 30 grams.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Intervention: &lt;/strong&gt;The research team induced PUs in all mice using neodymium magnets capable of forming approximately 1000 Gauss of magnetic force.The team randomly divided the mice into four groups,with seven animals in each group: (1) the control group,which received an injecition if dimethyl sulfoxide (DMSO) only; (2) the curcumin group,which received an injection of 200 mg/kg of curcumin in DMSO; (3) the fish oil group,which received an injection of fish oil; and (4) the curcumin+fish oil group,which received an injection of 200 mg/kg of curcumin in DMSO and fish oil.The mice received all injections intraperitoneally.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Outcome measures: &lt;/strong&gt;To determine a wound's severity, the healing process, and nonhealing tissue, the research team examined the tissues separately: (1) dor degree of ulceration, (2) inflammation, (3) reepithelization, (4) neovascularization, and (5) granulation.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;The study found third-degree pressure ulcer in all groups. No significant differences existed between the groups in terms of inflammation, which occurred in the control group with a maximum rate of 41.2%. The formation of reepithelization showed a significant difference between groups. Complete reepithelization ratios was higher in the fish oil group with 50% than the curcumin group and curcumin + fish oil group with 25%. Partiel reepithelization was seen with 46.1% highest ratio in curcumin + fish oil group. For neovascularization, the highest rate occurred in the curcumin +fish oil group at 75% at &gt;10 vessels per high power field (HPF) variable, and second highest ratio with 25% was curcumin group. Also 6-10 vessels per HPF (100%) was seen 42.9% in curcumin group and 42.9% in curcumin and fish oil group. Thus, amount of vessels were more in curcumin and fish oil group and curcumin group than control group and fish oil group. For formation of 3th degree granulation, the highest rate occurred in the fish oil group at 46.2% and second highest ratio was seen in curcumin + fish oil group with 38%. 2nd degree granulation was seen 55.6% in curcumin group. Thus, giving treatment induces the granulation that seen the lowest granulation in control group with 100%.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions: &lt;/strong&gt;The current res","PeriodicalId":7571,"journal":{"name":"Alternative therapies in health and medicine","volume":" ","pages":""},"PeriodicalIF":1.9,"publicationDate":"2025-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145123907","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Jama H. Lambert: What it Means to be Gluten-Free. Jama H. Lambert:无麸质意味着什么?
IF 1.9 4区 医学 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-09-01
Jama H Lambert, Sheldon Baker
{"title":"Jama H. Lambert: What it Means to be Gluten-Free.","authors":"Jama H Lambert, Sheldon Baker","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":7571,"journal":{"name":"Alternative therapies in health and medicine","volume":"31 5","pages":"6-9"},"PeriodicalIF":1.9,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144758956","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bibliometric Analysis of India's Ayush Systems of Medicine Using Ayush Research Portal Data from 1954-2020: Current Status, Challenges, and the Way Forward for Future Research. 使用1954-2020年阿尤什研究门户网站数据对印度阿尤什医学系统进行文献计量分析:现状、挑战和未来研究的前进方向。
IF 1.9 4区 医学 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-08-28
Sendhilkumar Muthappan, Natarajan Shanmugasundaram, Sainath Podugu, Anbarasi Chandrasekaran, Keerthiga Govindarajan, Shruthi Ramesh, Saketh Ram Thrigulla, Manickam Ponnaiah

Background: Research quality in Ayush systems of medicine is vital for evidence synthesis and decision-making. As Ayush gains global recognition, analyzing its trends and challenges is important for improving clinical outcomes. However, a comprehensive analysis of research publications is lacking.

Primary study objective: We conducted a bibliometric analysis using data from the Ayush research portal to highlight key trends and challenges in this field.

Methods: We extracted data from the Ayush Research Portal (ARP) database for the years 1954 to 2020, excluding books, workshops, conference papers, and incomplete entries. Our analysis evaluated the types of Ayush systems, authors' countries, publication years, author contributions, and the predatory status of journals. We used Epi Info (version 7.2) and Quantum GIS software for data analysis and map creation.

Results: We included 24 037 articles for analysis. Our findings indicate a gradual increase in publications starting from 2000, followed by exponential growth from 2009, and a peak in 2011. Most articles focused on preclinical research (n=10 677; 44.0%). India leads in the quantity of publications (n=20 675; 86.0%), followed by the US (n=649; 2.7%). Within India, Tamil Nadu accounted for the highest number of publications (n=3517; 17.0%). Furthermore, approximately 10% of the journals and one-third of the articles (7268; 30%) were classified as predatory.

Conclusion: This bibliometric review highlights a rise in publications across all systems, but raises concerns about quality, with one-third appearing in predatory journals. Thus, the Ayush systems of medicine should focus more on publication quality.

Keywords: complementary therapies, Ayurveda, traditional medicine, Ayush research portal.

背景:医学Ayush系统的研究质量对证据合成和决策至关重要。随着Ayush获得全球认可,分析其发展趋势和面临的挑战对于改善临床结果非常重要。然而,缺乏对研究出版物的全面分析。主要研究目标:我们使用来自Ayush研究门户网站的数据进行了文献计量分析,以突出该领域的主要趋势和挑战。方法:我们从Ayush Research Portal (ARP)数据库中提取1954年至2020年的数据,不包括书籍、研讨会、会议论文和不完整的条目。我们的分析评估了Ayush系统的类型、作者所在国家、出版年份、作者贡献和期刊的掠夺性状况。我们使用Epi Info(7.2版本)和Quantum GIS软件进行数据分析和地图创建。结果:纳入24037篇文献进行分析。我们的研究结果表明,论文发表量从2000年开始逐渐增加,随后从2009年开始呈指数增长,并在2011年达到顶峰。大多数文章集中于临床前研究(n=10 677; 44.0%)。印度在出版物数量上领先(n= 20675; 86.0%),其次是美国(n=649; 2.7%)。在印度,泰米尔纳德邦的出版物数量最多(n=3517; 17.0%)。此外,大约10%的期刊和三分之一的文章(7268篇;30%)被归类为掠夺性。结论:这篇文献计量学综述强调了所有系统中出版物的增加,但引起了对质量的担忧,其中三分之一出现在掠夺性期刊上。因此,医学的Ayush系统应该更多地关注出版质量。关键词:补充疗法,阿育吠陀,传统医学,阿尤什研究门户。
{"title":"Bibliometric Analysis of India's Ayush Systems of Medicine Using Ayush Research Portal Data from 1954-2020: Current Status, Challenges, and the Way Forward for Future Research.","authors":"Sendhilkumar Muthappan, Natarajan Shanmugasundaram, Sainath Podugu, Anbarasi Chandrasekaran, Keerthiga Govindarajan, Shruthi Ramesh, Saketh Ram Thrigulla, Manickam Ponnaiah","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Research quality in Ayush systems of medicine is vital for evidence synthesis and decision-making. As Ayush gains global recognition, analyzing its trends and challenges is important for improving clinical outcomes. However, a comprehensive analysis of research publications is lacking.</p><p><strong>Primary study objective: </strong>We conducted a bibliometric analysis using data from the Ayush research portal to highlight key trends and challenges in this field.</p><p><strong>Methods: </strong>We extracted data from the Ayush Research Portal (ARP) database for the years 1954 to 2020, excluding books, workshops, conference papers, and incomplete entries. Our analysis evaluated the types of Ayush systems, authors' countries, publication years, author contributions, and the predatory status of journals. We used Epi Info (version 7.2) and Quantum GIS software for data analysis and map creation.</p><p><strong>Results: </strong>We included 24 037 articles for analysis. Our findings indicate a gradual increase in publications starting from 2000, followed by exponential growth from 2009, and a peak in 2011. Most articles focused on preclinical research (n=10 677; 44.0%). India leads in the quantity of publications (n=20 675; 86.0%), followed by the US (n=649; 2.7%). Within India, Tamil Nadu accounted for the highest number of publications (n=3517; 17.0%). Furthermore, approximately 10% of the journals and one-third of the articles (7268; 30%) were classified as predatory.</p><p><strong>Conclusion: </strong>This bibliometric review highlights a rise in publications across all systems, but raises concerns about quality, with one-third appearing in predatory journals. Thus, the Ayush systems of medicine should focus more on publication quality.</p><p><strong>Keywords: </strong>complementary therapies, Ayurveda, traditional medicine, Ayush research portal.</p>","PeriodicalId":7571,"journal":{"name":"Alternative therapies in health and medicine","volume":" ","pages":""},"PeriodicalIF":1.9,"publicationDate":"2025-08-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144939044","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of Heat Application on Pain, Anxiety, and Comfort Levels of Patients Undergoing Cystoscopy: A Randomized Controlled Trial. 热敷对膀胱镜检查患者疼痛、焦虑和舒适度的影响:一项随机对照试验。
IF 1.9 4区 医学 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-08-28
Emine Karakaya, Kıvan Çevik Kaya

Background: Cystoscopy causes pain, anxiety, and dissatisfaction in patients and leads to increased discomfort. Therefore, it is helpful to use pharmacological and evidence-based complementary alternative medicine methods together for pain, anxiety, and comfort management during the cystoscopy procedure.

Objective: This randomized controlled experimental study was conducted to determine the effects of heat application on patients' pain, anxiety, and comfort levels during cystoscopy.

Methods: This study was conducted as a two-parallel group randomized controlled trial, from November 2023 to June 2024.

Setting: The study was conducted in the cystoscopy unit of a state hospital located in Western Turkey.

Participants: The study sample consisted of 62 patients.

Intervention: The patients were randomly assigned to two groups using a computer program (www.randomizer.org): Group 1 (control group) and Group 2 (intervention group). The patients in the intervention group underwent heat application in the cystoscopy room.

Primary outcome measures: Data were collected using the 'Patient Information Form', 'Visual Analog Scale', 'Data Recording Form', 'State Anxiety Inventory', and 'Shortened General Comfort Scale'. While the data were analyzed, descriptive statistical methods, chi-square analysis, independent samples t test, dependent samples t test, and analysis of variance test were used.

Results: There was a statistically significant difference between the intervention and control groups in terms of the mean scores obtained from the VAS during and after the intervention, but there was no statistically significant difference between the scores obtained from the overall State Anxiety Inventory and Shortened General Comfort Scale and their subscales before and after the intervention.

Conclusion: The study findings indicate that the heat application to patients during cystoscopy is effective in reducing pain.

Keywords: anxiety, comfort, cystoscopy, heat application, pain, complementary and alternative medicine.

背景:膀胱镜检查引起患者疼痛、焦虑和不满,并导致不适增加。因此,在膀胱镜检查过程中,使用药理学和循证补充替代医学方法对疼痛、焦虑和舒适管理是有帮助的。目的:本随机对照实验研究旨在确定热敷对膀胱镜检查患者疼痛、焦虑和舒适水平的影响。方法:本研究采用双平行组随机对照试验,研究时间为2023年11月至2024年6月。环境:该研究是在位于土耳其西部的一家国立医院的膀胱镜检查部门进行的。参与者:研究样本包括62例患者。干预:采用计算机程序(www.randomizer.org)将患者随机分为两组:1组(对照组)和2组(干预组)。干预组患者在膀胱镜室进行热敷。主要结果测量:使用“患者信息表”、“视觉模拟量表”、“数据记录表”、“状态焦虑量表”和“缩短一般舒适量表”收集数据。在分析资料时,采用描述性统计方法、卡方分析、独立样本t检验、相关样本t检验和方差分析检验。结果:干预组在干预期间和干预后的VAS平均得分与对照组比较,差异均有统计学意义,但干预前后总体状态焦虑量表和缩短一般舒适量表及其子量表得分差异均无统计学意义。结论:膀胱镜检查时热敷能有效减轻患者疼痛。关键词:焦虑、舒适、膀胱镜检查、热敷、疼痛、补充替代医学。
{"title":"Effects of Heat Application on Pain, Anxiety, and Comfort Levels of Patients Undergoing Cystoscopy: A Randomized Controlled Trial.","authors":"Emine Karakaya, Kıvan Çevik Kaya","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Cystoscopy causes pain, anxiety, and dissatisfaction in patients and leads to increased discomfort. Therefore, it is helpful to use pharmacological and evidence-based complementary alternative medicine methods together for pain, anxiety, and comfort management during the cystoscopy procedure.</p><p><strong>Objective: </strong>This randomized controlled experimental study was conducted to determine the effects of heat application on patients' pain, anxiety, and comfort levels during cystoscopy.</p><p><strong>Methods: </strong>This study was conducted as a two-parallel group randomized controlled trial, from November 2023 to June 2024.</p><p><strong>Setting: </strong>The study was conducted in the cystoscopy unit of a state hospital located in Western Turkey.</p><p><strong>Participants: </strong>The study sample consisted of 62 patients.</p><p><strong>Intervention: </strong>The patients were randomly assigned to two groups using a computer program (www.randomizer.org): Group 1 (control group) and Group 2 (intervention group). The patients in the intervention group underwent heat application in the cystoscopy room.</p><p><strong>Primary outcome measures: </strong>Data were collected using the 'Patient Information Form', 'Visual Analog Scale', 'Data Recording Form', 'State Anxiety Inventory', and 'Shortened General Comfort Scale'. While the data were analyzed, descriptive statistical methods, chi-square analysis, independent samples t test, dependent samples t test, and analysis of variance test were used.</p><p><strong>Results: </strong>There was a statistically significant difference between the intervention and control groups in terms of the mean scores obtained from the VAS during and after the intervention, but there was no statistically significant difference between the scores obtained from the overall State Anxiety Inventory and Shortened General Comfort Scale and their subscales before and after the intervention.</p><p><strong>Conclusion: </strong>The study findings indicate that the heat application to patients during cystoscopy is effective in reducing pain.</p><p><strong>Keywords: </strong>anxiety, comfort, cystoscopy, heat application, pain, complementary and alternative medicine.</p>","PeriodicalId":7571,"journal":{"name":"Alternative therapies in health and medicine","volume":" ","pages":""},"PeriodicalIF":1.9,"publicationDate":"2025-08-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144938767","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of Cupping Therapy on Metabolite (Blood Sugar, Blood Pressure, and Lipid Profiles) Results in Women: A Systematic Review. 拔火罐治疗对女性代谢物(血糖、血压和血脂)结果的影响:一项系统综述。
IF 1.9 4区 医学 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-08-28
Semra PhD Yilmaz, Emine Kaplan Serin

Background: Cupping Therapy is an ancient therapeutic practice used to treat a wide variety of medical conditions.

Aim: The study aimed to systematically review randomized controlled and quasi-experimental studies evaluating the effectiveness of cupping therapy on metabolite outcomes, specifically blood glucose, blood pressure, and lipid profiles in women.

Methods: The systematic review was conducted following PRISMA-P (Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols) guidelines. A comprehensive literature search was carried out between January and May 2024 using PubMed, Web of Science, Scopus, CINAHL, and the Cochrane Library. Inclusion and exclusion criteria were determined using the PICOS framework, and the quality of the studies was assessed using the Joanna Briggs Institute (JBI) critical appraisal tool.

Results: The analysis included data from 307 female participants who met the inclusion criteria and participated in six randomized controlled or quasi-experimental studies. The findings indicated that cupping therapy had a positive effect on several metabolic parameters. Significant associations were observed between cupping therapy and improvements in blood pressure, blood glucose levels, and lipid profiles. None of the included studies reported adverse effects related to cupping therapy in women.

Conclusion: Cupping therapy can improve blood pressure, blood glucose, and lipid levels in women. However, further high-quality studies with larger sample sizes, rigorous randomization, and blinding are needed to fully understand the therapeutic potential and mechanisms of action of cupping therapy.

Keywords: cupping therapy, metabolite results, systematic review, wet cupping therapy, women.

背景:拔火罐疗法是一种古老的治疗方法,用于治疗各种各样的疾病。目的:本研究旨在系统回顾随机对照和准实验研究,评估拔火罐治疗对代谢物结果的有效性,特别是女性的血糖、血压和脂质谱。方法:按照PRISMA-P(系统评价和荟萃分析方案的首选报告项目)指南进行系统评价。在2024年1月至5月期间,使用PubMed、Web of Science、Scopus、CINAHL和Cochrane Library进行了全面的文献检索。采用PICOS框架确定纳入和排除标准,采用乔安娜布里格斯研究所(JBI)关键评估工具评估研究质量。结果:分析纳入了符合纳入标准的307名女性参与者的数据,并参加了6项随机对照或准实验研究。结果表明,拔火罐治疗对一些代谢参数有积极的影响。在拔火罐治疗与血压、血糖水平和血脂的改善之间观察到显著的关联。纳入的研究均未报告拔火罐治疗对女性的不良影响。结论:拔火罐治疗可改善女性血压、血糖和血脂水平。然而,为了充分了解拔罐疗法的治疗潜力和作用机制,需要进一步开展更大样本量、严格随机化和盲法的高质量研究。关键词:拔罐疗法,代谢物结果,系统评价,湿罐疗法,女性。
{"title":"Effect of Cupping Therapy on Metabolite (Blood Sugar, Blood Pressure, and Lipid Profiles) Results in Women: A Systematic Review.","authors":"Semra PhD Yilmaz, Emine Kaplan Serin","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Cupping Therapy is an ancient therapeutic practice used to treat a wide variety of medical conditions.</p><p><strong>Aim: </strong>The study aimed to systematically review randomized controlled and quasi-experimental studies evaluating the effectiveness of cupping therapy on metabolite outcomes, specifically blood glucose, blood pressure, and lipid profiles in women.</p><p><strong>Methods: </strong>The systematic review was conducted following PRISMA-P (Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols) guidelines. A comprehensive literature search was carried out between January and May 2024 using PubMed, Web of Science, Scopus, CINAHL, and the Cochrane Library. Inclusion and exclusion criteria were determined using the PICOS framework, and the quality of the studies was assessed using the Joanna Briggs Institute (JBI) critical appraisal tool.</p><p><strong>Results: </strong>The analysis included data from 307 female participants who met the inclusion criteria and participated in six randomized controlled or quasi-experimental studies. The findings indicated that cupping therapy had a positive effect on several metabolic parameters. Significant associations were observed between cupping therapy and improvements in blood pressure, blood glucose levels, and lipid profiles. None of the included studies reported adverse effects related to cupping therapy in women.</p><p><strong>Conclusion: </strong>Cupping therapy can improve blood pressure, blood glucose, and lipid levels in women. However, further high-quality studies with larger sample sizes, rigorous randomization, and blinding are needed to fully understand the therapeutic potential and mechanisms of action of cupping therapy.</p><p><strong>Keywords: </strong>cupping therapy, metabolite results, systematic review, wet cupping therapy, women.</p>","PeriodicalId":7571,"journal":{"name":"Alternative therapies in health and medicine","volume":" ","pages":""},"PeriodicalIF":1.9,"publicationDate":"2025-08-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144938603","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy of Individualized Homeopathic Treatment in Uncomplicated Odontogenic Infections: A Randomized, Double-blind, Placebo-controlled Clinical Trial. 个体化顺势疗法治疗无并发症牙源性感染的疗效:一项随机、双盲、安慰剂对照的临床试验。
IF 1.9 4区 医学 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-08-28
Sushanta Sasmal, Samit Dey, Shubhamoy Ghosh, Anjani Kumar Rai, Abhijit Dutta

Background: Odontogenic infections are among the most common problems encountered in usual dental practice. The role and efficacy of complementary treatments such as individualized homeopathy are not well characterized.

Methods: A double-blind, randomized, placebo-controlled clinical trial enrolled 60 patients with uncomplicated odontogenic infections. Patients were randomly assigned to receive either Individualized Homeopathy (IH, n=30) or Placebo (PL, n=30), in addition to non-medicinal management. Co-primary outcome measures included Visual Analog Scales for Pain (VAS-P) and Swelling (VAS-S). Secondary outcome measures comprised the Oral Health Impact Profile-14 (OHIP-14) and time taken for complete symptom resolution (Ts). All outcomes were assessed at baseline, 3rd day, 7th day, and 14th day, except Ts, which was monitored daily until symptoms completely resolved within 14 days.

Results: IH showed significant improvement over PL in VAS-P at day 7 (P = .005) and day 14 (P < .001), as well as in VAS-S at day 7 (P = .001) and day 14 (P < .001). OHIP-14 improvement post-treatment was notably higher in IH than PL (F=3.404, P < .05). Kaplan-Meier analysis revealed a significant difference in Ts (P = .015), with reduced hazard in the PL group (Hazard Ratio = 0.3024, 95% CI: 0.1087-0.8414). The most prescribed medicines in the IH group were Mercurius solubilis (16.6%) and Hypericum perfoliatum (13.3%), whereas in the PL group, the most indicated medicines were Mercurius solubilis (13.3%) and Staphysagria (13.3%).

Conclusion: This study demonstrated a significant therapeutic effect of homeopathy over placebo in alleviating pain and swelling linked to odontogenic infections. Nevertheless, to firmly establish this finding, a large-scale replication trial employing a similar methodology is deemed necessary.

Keywords: homeopathy, odontogenic infections, randomized controlled trial, placebo, dental infections.

背景:牙源性感染是常见的牙科问题之一。补充疗法如个体化顺势疗法的作用和疗效还没有很好地描述。方法:一项双盲、随机、安慰剂对照的临床试验纳入了60例无并发症的牙源性感染患者。除了非药物治疗外,患者被随机分配接受个体化顺势疗法(IH, n=30)或安慰剂(PL, n=30)。共同主要结局指标包括疼痛视觉模拟量表(VAS-P)和肿胀视觉模拟量表(VAS-S)。次要结局指标包括口腔健康影响概况-14 (OHIP-14)和症状完全缓解所需的时间(Ts)。在基线、第3天、第7天和第14天评估所有结果,t除外,t每天监测,直到症状在14天内完全消退。结果:IH在VAS-P第7天(P = 0.005)和第14天(P < 0.001)以及VAS-S第7天(P = 0.001)和第14天(P < 0.001)较PL有显著改善。IH治疗后OHIP-14改善率显著高于PL (F=3.404, P < 0.05)。Kaplan-Meier分析显示Ts差异显著(P = 0.015), PL组的风险降低(风险比= 0.3024,95% CI: 0.1087-0.8414)。IH组处方用药最多的是溶汞(16.6%)和细叶金丝桃(13.3%),而PL组指征用药最多的是溶汞(13.3%)和葡萄球菌(13.3%)。结论:本研究表明顺势疗法在缓解牙源性感染引起的疼痛和肿胀方面比安慰剂有显著的治疗效果。然而,为了牢固地确立这一发现,采用类似方法的大规模重复试验被认为是必要的。关键词:顺势疗法,牙源性感染,随机对照试验,安慰剂,牙齿感染。
{"title":"Efficacy of Individualized Homeopathic Treatment in Uncomplicated Odontogenic Infections: A Randomized, Double-blind, Placebo-controlled Clinical Trial.","authors":"Sushanta Sasmal, Samit Dey, Shubhamoy Ghosh, Anjani Kumar Rai, Abhijit Dutta","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Odontogenic infections are among the most common problems encountered in usual dental practice. The role and efficacy of complementary treatments such as individualized homeopathy are not well characterized.</p><p><strong>Methods: </strong>A double-blind, randomized, placebo-controlled clinical trial enrolled 60 patients with uncomplicated odontogenic infections. Patients were randomly assigned to receive either Individualized Homeopathy (IH, n=30) or Placebo (PL, n=30), in addition to non-medicinal management. Co-primary outcome measures included Visual Analog Scales for Pain (VAS-P) and Swelling (VAS-S). Secondary outcome measures comprised the Oral Health Impact Profile-14 (OHIP-14) and time taken for complete symptom resolution (Ts). All outcomes were assessed at baseline, 3rd day, 7th day, and 14th day, except Ts, which was monitored daily until symptoms completely resolved within 14 days.</p><p><strong>Results: </strong>IH showed significant improvement over PL in VAS-P at day 7 (P = .005) and day 14 (P < .001), as well as in VAS-S at day 7 (P = .001) and day 14 (P < .001). OHIP-14 improvement post-treatment was notably higher in IH than PL (F=3.404, P < .05). Kaplan-Meier analysis revealed a significant difference in Ts (P = .015), with reduced hazard in the PL group (Hazard Ratio = 0.3024, 95% CI: 0.1087-0.8414). The most prescribed medicines in the IH group were Mercurius solubilis (16.6%) and Hypericum perfoliatum (13.3%), whereas in the PL group, the most indicated medicines were Mercurius solubilis (13.3%) and Staphysagria (13.3%).</p><p><strong>Conclusion: </strong>This study demonstrated a significant therapeutic effect of homeopathy over placebo in alleviating pain and swelling linked to odontogenic infections. Nevertheless, to firmly establish this finding, a large-scale replication trial employing a similar methodology is deemed necessary.</p><p><strong>Keywords: </strong>homeopathy, odontogenic infections, randomized controlled trial, placebo, dental infections.</p>","PeriodicalId":7571,"journal":{"name":"Alternative therapies in health and medicine","volume":" ","pages":""},"PeriodicalIF":1.9,"publicationDate":"2025-08-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144938706","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Alternative therapies in health and medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1